"Yinchuan City SLOW disease management - slow lung patients digital management project" officially launched.

Guide: To help the construction of "Internet plus medical health" and explore the innovative management mode of slow-impedance lung.
, Aug. 18, 2020 /USC/ -- On August 18, 2020, the Yinchuan City Health And Health Committee, the Yinchuan City Slow Disease Management-Digital Management Project for Patients with Slow Lung, hosted by Airscape Internet Hospital and GlaxoSmithKline (GSK), was officially launched.
The project is an extension and expansion of the chronic disease management system in Yinchuan City, the project is committed to the pioneering exploration of the "Internet and medical health" based on the slow-impedance lung line offline integrated management model, and actively build a respiratory chronic disease management intelligent medical demonstration system, to help improve the overall management level of china's slow-impulsive lung standardization diagnosis and treatment.
"Yinchuan City Slow Disease Management - Digital Management Project for Patients with Slow Lung" officially launched the "Opinion on Promoting the Development of "Internet and Medical Health" issued by the State Council (hereinafter referred to as "Opinion"), emphasizing the use of the Internet and other information technology to expand the space and content of medical services, build an online and offline integrated medical service model covering pre-diagnosis, diagnosis and post-diagnosis, and improve the Internet-based, big data technology-based grading diagnosis and treatment information system.
, "Opinion" emphasizes the promotion of the use of "Internet Plus" in health care management, especially slow disease screening and active intervention.
1 new research shows that the number of patients with chronic obstructive pulmonary disease (hereinafter referred to as chronic obstructive pulmonary disease) in China reached nearly 100 million, has become the third largest chronic disease in China, but more than 80% of them have not been standardized diagnosis and treatment.
2 Based on this background, in March 2019, Yinchuan City Health Committee and GSK signed a strategic cooperation agreement, "Yinchuan City slow disease management - digital management of patients with chronic pulmonary disease" launch will further implement the Internet and other information technology in the management of chronic lung disease in the actual The use, the use of digital technology, open the front-end hospital visits and back-end out-of-hospital monitoring of chronic disease management closed loop, is committed to building the country's first digital ecological management system of slow-blocking lung, for China to explore digital medical model innovation and slow-blocking lung standardized diagnosis and treatment and long-term management to establish a model role, set up an industry model.
Li Jiyue, deputy director of Yinchuan City Health And Health Committee, said: "The launch and landing of the 'Yinchuan City Slow Disease Management- Digital Management Project for Patients with SLOW Lung' is a breakthrough after the signing of a strategic cooperation agreement in March 2019, and also a breakthrough in Yinchuan City's management of chronic diseases from 'the management of a single hospital for patients with slow lung disease' to the 'combination of in-hospital and out-of-hospital management of patients with slow lung', which solidly benefits the people.
, as an important initiative of the Yinchuan City Slow Disease Management-Digital Management Project for Patients with Slow Lung, was officially unveiled on the same day at the "Digital Management Innovation Center for Respiratory Diseases" at Yinchuan First People's Hospital.
The Center is committed to creating an innovative slow disease management system by using advanced information technology such as digitalization, "Internet plus medical health", 5G, Internet of Things, etc., to provide a number of healthy big data analysis services for patients with chronic respiratory diseases.
's "Digital Management Innovation Center for Respiratory Diseases"," the core facility of the Slow Lung Patient Management Real-Time Data Big Screen, will also be launched this month, with dynamic real-time monitoring of key disease indicators such as lung function, blood oxygen, pulse and home treatment for patients with THM through the integration of intelligent wearable devices and Internet of Things sensors.
In full combination with artificial intelligence, big data technology and Yinchuan City family doctor contract management system, real-time assessment of the progress of the disease of patients with slow lung, for patients with high probability of acute attack or their family doctors to give timely medical intervention guidance, effectively improve the level and efficiency of disease management of patients with chronic diseases.
In order to further expand Yinchuan's "Internet plus Medical" services to cover eight outpatient major diseases, including chronic pulmonary diseases, GSK will jointly carry out the "Innovative Primary Care Services" project with Aviation News Agency Internet Hospital, the first Internet of Things digitally supported chronic lung patients project in Yinchuan, China.
Relies on the professional capabilities of The First People's Hospital of Yinchuan City and the Third People's Hospital of Yinchuan City through GSK's innovative IoT sensor technology solutions and a team of health care professionals from Airscape, the project aims to accelerate the exploration of the medical union model of respiratory disease management through digital means.
Through the new mechanism of digital management, the patient is provided with the service of personal disease files such as disease data preservation and teaching records, and provides new forms of disease management to patients through various channels, such as lung function assessment, symptom assessment, acute seizures and admissions, and patient medication compliance.
The initial project is expected to achieve the management of 1000 patients diagnosed with THM, is committed to providing patients with standardized management of THM disease, focusing on improving the compliance of patients with THM medication, and effectively improve the health status of patients with THM. "As one of the first Internet hospital enterprises in The Nation, we have been committed to providing convenient, professional and accurate one-stop medical services and health management services for patients with chronic diseases since its inception," said Mr. Wang Wei, Chairman of the Internet Hospital of
Airscape.
in Yinchuan, we are also the first Internet hospital to successfully realize the medical insurance outpatient major disease online settlement of medical insurance reimbursement.
Three time and GSK jointly carry out 'Yinchuan City slow disease management - slow lung digital management project', is our follow-up to hypertension O2O management, diabetes MDM management of another chronic disease management model extension and exploration, the core of which is through the stratized co-management services, to a full range of professional out-of-hospital management model to effectively improve the health status of patients with slow lung disease in Yinchuan City, stabilize the disease, reduce complications, improve the quality of life and home health management level.
Qi Xin, vice president of GSK and general manager of prescription drugs and vaccines in China for more than 30 years, has been working closely with the Chinese government, relevant units and clinicians to bring innovative respiratory disease treatment solutions to Chinese patients through advanced digitalization, Internet of Things, big data and other information technologies, while accelerating the sinking of high-quality medical resources and improving disease management capabilities in the western region.
the future, GSK will work with industry partners from all walks of life to continuously promote the construction of innovative ecosystems in the medical industry, jointly raise the level of prevention and treatment of slow-impedance lung, and contribute to the construction of the 'Healthy China 2030' grand blueprint.
"